Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Technology
Vandana Singh

Alnylam Hits Pfizer, Moderna With Patent Infringement Suits

  • Alnylam Pharmaceuticals Inc (NASDAQ:ALNY) has filed separate lawsuits in the Delaware federal court against Pfizer Inc (NYSE:PFE) and Moderna Inc (NASDAQ:MRNA), seeking damages for infringement of a patent in the manufacture and sale of their mRNA COVID-19 vaccines.
  • Alnylam said it was seeking compensation for the use of its lipid nanoparticles (LNP) technology that carries and delivers RNA-based therapeutics or vaccines in the body.
  • The pharmaceutical firm said that Pfizer and Moderna's vaccines infringe Alnylam's patent by using a lipid formulated into LNPs that protect and deliver the vaccines' mRNA.
  • Read Next: Arbutus Hits Moderna With New Suit Claiming COVID-19 Vaccine Patent(s).
  • Alnylam said it does not intend to take action that impedes the vaccines' production, sale, or distribution.
  • Price Action: PFE stock is up 2.15% at $54.06 during the market session on the last check Thursday.
Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.